Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[The therapy of acute myeloid leukemia in patients of advanced age].
Kern W, Schoch C, Fonatsch C, Heinecke A, Wörmann B, Büchner T, Hiddemann W. Kern W, et al. Dtsch Med Wochenschr. 1999 Aug 27;124(34-35):1005-14. doi: 10.1055/s-2007-1024465. Dtsch Med Wochenschr. 1999. PMID: 10488328 Review. German. No abstract available.
Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial.
Kern W, Haferlach T, Schoch C, Loffler H, Gassmann W, Heinecke A, Sauerland MC, Berdel W, Buchner T, Hiddemann W. Kern W, et al. Blood. 2003 Jan 1;101(1):64-70. doi: 10.1182/blood-2002-02-0532. Epub 2002 Jun 28. Blood. 2003. PMID: 12393605 Free article. Clinical Trial.
Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
Haferlach T, Schoch C, Löffler H, Gassmann W, Kern W, Schnittger S, Fonatsch C, Ludwig WD, Wuchter C, Schlegelberger B, Staib P, Reichle A, Kubica U, Eimermacher H, Balleisen L, Grüneisen A, Haase D, Aul C, Karow J, Lengfelder E, Wörmann B, Heinecke A, Sauerland MC, Büchner T, Hiddemann W. Haferlach T, et al. Among authors: kern w. J Clin Oncol. 2003 Jan 15;21(2):256-65. doi: 10.1200/JCO.2003.08.005. J Clin Oncol. 2003. PMID: 12525517
[Diagnostics and therapy of acute myeloid leukemia].
Kern W, Haferlach T, Schoch C, Hiddemann W. Kern W, et al. Dtsch Med Wochenschr. 2002 Oct 18;127(42):2208-13. doi: 10.1055/s-2002-34943. Dtsch Med Wochenschr. 2002. PMID: 12397550 German. No abstract available.
[Diagnosis of leukemia using microarray technology].
Kohlmann A, Schoch C, Schnittger S, Kern W, Haferlach T. Kohlmann A, et al. Among authors: kern w. Dtsch Med Wochenschr. 2002 Oct 18;127(42):2216-22. doi: 10.1055/s-2002-34945. Dtsch Med Wochenschr. 2002. PMID: 12397553 German. No abstract available.
Genetic classification of acute myeloid leukemia (AML).
Haferlach T, Schnittger S, Kern W, Hiddemann W, Schoch C. Haferlach T, et al. Among authors: kern w. Ann Hematol. 2004;83 Suppl 1:S97-100. doi: 10.1007/s00277-004-0850-2. Ann Hematol. 2004. PMID: 15124693 Review.
1,211 results